# Bibliometric analysis combined with visualization on universal trends and hot topics of LOX family in human diseases: 1995 to 2025

**Authors:** Tingting Yang, Heng Li, Wenxuan Zhou, Ning Zhang, Zhenyu Tian, Heming Wang, Yuyan Feng, Yunguang Chen, Zhen Wang

PMC · DOI: 10.3389/fonc.2025.1601261 · Frontiers in Oncology · 2025-06-30

## TL;DR

This paper analyzes 30 years of research on the LOX family of enzymes, showing their role in diseases and highlighting trends in scientific interest and potential future directions.

## Contribution

The study provides a comprehensive bibliometric and visual analysis of LOX research trends from 1995 to 2025.

## Key findings

- There were 9,261 LOX-related publications identified, with a significant increase in the past decade.
- The United States, China, and Japan led in publication output, with Harvard and Boston Universities being highly productive.
- LOX research is linked to cancer, fibrosis, and cardiovascular diseases, with potential for new diagnostics and treatments.

## Abstract

Lysyl oxidase (LOX) is crucial for modifying collagen and elastin, thereby preserving tissue integrity. Aberrant LOX activity has been associated with a multitude of health disorders, including cutaneous, pulmonary, fibrotic, cardiovascular diseases, and cancer. In cancer, LOX can either promote or inhibit tumor development, and its expression level is closely correlated with patient prognosis.

This research utilized data retrieved from the Web of Science Core Collection on May 30, 2025. The search strategies were crafted to target LOX – related terms while excluding irrelevant ones, and the data were limited to English – language articles. Over the past 30 years, 9261 LOX – related publications were identified. The number of articles exhibited an upward trend, especially in the past decade. The United States, China, and Japan were the leading countries in terms of publication output, with institutions like Harvard University and Boston University being highly productive.

This research utilized data retrieved from the Web of Science Core Collection on May 30, 2025. The search strategies were crafted to target LOX – related terms while excluding irrelevant ones, and the data were limited to English – language articles. Over the past 30 years, 9261 LOX – related publications were identified. The number of articles exhibited an upward trend, especially in the past decade. The United States, China, and Japan were the leading countries in terms of publication output, with institutions like Harvard University and Boston University being highly productive.

This study presents an overview of LOX - related research. Comprehending the mechanisms of LOX can offer valuable perspectives on tumor biology. Future research on LOX – extracellular matrix interactions and associated gene pathways may lead to the development of novel diagnostic and treatment modalities targeting LOX.

## Linked entities

- **Proteins:** LOX (lysyl oxidase)
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, ELN (elastin) [NCBI Gene 2006] {aka ADCL1, SVAS, WBS, WS}
- **Diseases:** cardiovascular diseases (MESH:D002318), cancer (MESH:D009369), , pulmonary, fibrotic (MESH:D008171)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12256254/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12256254/full.md

## References

124 references — full list in the complete paper: https://tomesphere.com/paper/PMC12256254/full.md

---
Source: https://tomesphere.com/paper/PMC12256254